Faulds; Daryl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Faulds; Daryl.The latest application filed is for "ep2 and ep4 agonists as agents for the treatment of influenza a viral infection".

Company Profile

0.7.14

Faulds; Daryl - Millbrae CA
Faulds; Daryl - Mill Valley CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ep2 And Ep4 Agonists As Agents For The Treatment Of Influenza A Viral Infection App 20150374715 - Faulds; Daryl ; et al.	2015-12-31
EP2 and EP4 agonists as agents for the treatment of influenza a viral infection Grant 8,980,944 - Faulds , et al. March 17, 2	2015-03-17
Ep2 And Ep4 Agonists As Agents For The Treatment Of Influenza A Viral Infection App 20120190739 - Faulds; Daryl ; et al.	2012-07-26
EP2 and EP4 agonists as agents for the treatment of influenza a viral infection Grant 8,183,286 - Faulds , et al. May 22, 2	2012-05-22
9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments Grant 7,563,924 - Buchmann , et al. July 21, 2	2009-07-21
EP2 and EP4 agonists as agents for the treatment of influenza a viral infection App 20090170931 - Faulds; Daryl ; et al.	2009-07-02
Novel fibroblast growth factors App 20080057076 - Bringmann; Peter W. ; et al.	2008-03-06
5-Cyano-prostacyclin derivatives as agents for the treatment of autoimmune disease App 20080021099 - Faulds; Daryl ; et al.	2008-01-24
9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments App 20070203096 - Buchmann; Bernd ; et al.	2007-08-30
Modulation of MDL-1 activity for treatment of inflammatory disease App 20070179094 - Faulds; Daryl ; et al.	2007-08-02
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008376 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008279 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008391 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030003447 - Doms, Robert W. ; et al.	2003-01-02
Novel fibroblast growth factors App 20020151496 - Bringmann, Peter W. ; et al.	2002-10-17
Methods And Compositions For Modulating The Interaction Between The Apj Receptor And The Hiv Virus App 20020062488 - DOMS, ROBERT W. ; et al.	2002-05-23
Novel interferon for the treatment of multiple sclerosis App 20020025304 - Croze, Edward M. ; et al.	2002-02-28
Chiral methylphenyloxazolidinones Grant 6,025,376 - Laurent , et al. February 15, 2	2000-02-15
Mycoplasma hyopneumoniae antigen and uses therefor Grant 5,252,328 - Faulds , et al. * October 12, 1	1993-10-12
Intranasal administration of Mycoplasma hyopneumoniae antigen Grant 5,240,706 - Faulds August 31, 1	1993-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.